unknown
Stage
About
D&D Pharmatech develops innovative peptide-based therapeutics focusing on metabolic diseases, including GLP-1 class drugs for obesity and MASH treatment, and advances pipeline candidates via global clinical trials.
Explore D&D Pharmatech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.